Bml Capital Management, LLC Portfolio Holdings

Bml Capital Management, LLC

  • $132 Billion
  • Q2 2025

Bml Capital Management, LLC has filed its 13F form on August 11, 2025 for Q2 2025 where it was disclosed a total value porftolio of $132 Billion distributed in 24 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Atea Pharmaceuticals, Inc. with a value of $27.4B, Third Harmonic Bio, Inc. with a value of $20.8B, Aclaris Therapeutics, Inc. with a value of $20.2B, Instil Bio Inc with a value of $11.1B, and Essa Pharma Inc. with a value of $7.18B.

Examining the 13F form we can see an increase of $8.62B in the current position value, from $124B to 132B.

Bml Capital Management, LLC is based out at Zionsville, IN

Below you can find more details about Bml Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $132 Billion
Healthcare: $104 Billion
Consumer Cyclical: $1.65 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 24
  • Current Value $132 Billion
  • Prior Value $124 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 11, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 1 stocks
  • Additional Purchases 10 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Bml Capital Management, LLC Portfolio

Follow Bml Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bml Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bml Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email